Position in VCEL
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$1,017,697
-$435,450 QoQ
Shares Held
31,635
-21.6% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sterling Capital Management LLC holds $38,253,389 across 229 Biotechnology names. VCEL ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,738 | $9,841,888 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,338 | $5,955,950 | |
| 3 | ASND |
Ascendis Pharma A/S
|
14,929 | $3,414,710 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
14,615 | $2,762,965 | |
| 5 | INSM |
INSMED Inc
|
12,993 | $2,124,615 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,182 | $1,714,568 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
11,343 | $1,103,106 | |
| 8 | VCEL |
Vericel Corp
This page
|
31,635 | $1,017,697 |
All Filings in VCEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,017,697 | 31,635 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,453,147 | 40,354 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,839 | 122 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,191 | 122 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,320 | 52 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,745 | 50 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,112 | 50 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||